Surgery Partners, Inc. (SGRY)
| Market Cap | 3.03B +3.7% |
| Revenue (ttm) | 3.37B +4.0% |
| Net Income | -88.60M |
| EPS | -0.69 |
| Shares Out | 129.71M |
| PE Ratio | n/a |
| Forward PE | 85.72 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,199,295 |
| Open | 23.20 |
| Previous Close | 23.25 |
| Day's Range | 23.13 - 23.37 |
| 52-Week Range | 11.41 - 23.44 |
| Beta | 1.91 |
| Analysts | Buy |
| Price Target | 21.20 (-9.25%) |
| Est. Earnings | Nov 9, 2026 |
About SGRY
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care faciliti... [Read more]
Financial Performance
In 2025, Surgery Partners's revenue was $3.31 billion, an increase of 6.24% compared to the previous year's $3.11 billion. Losses were -$77.90 million, -53.66% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price target is $21.2, which is a decrease of -9.25% from the latest price.
News
SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
NEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law.
Surgery Partners downgraded to Neutral from Buy at UBS
UBS analyst AJ Rice downgraded Surgery Partners (SGRY) to Neutral from Buy with a $23.50 price target following the company’s agreement to be acquired by HealthSpan Partners, an affiliate of…
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on October 27, 2026, providing details for shareholder voting and corporate governance matters.
Surgery Partners downgraded to Hold from Buy at StoneX
StoneX downgraded Surgery Partners (SGRY) to Hold from Buy following the company’s agreement to be acquired by HealthSpan Partners, an affiliate of Bon Secours Mercy Health, for $23.50 per share…
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $SGRY--SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law.
Surgery Partners downgraded to Neutral from Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James downgraded Surgery Partners (SGRY) to Neutral from Overweight with a $23.50 price target after the company agreed to be acquired by HealthSpan Partners for $23.50...
Bon Secours Affiliate to Acquire Surgery Partners in $5.7 Billion Take-Private Deal
Bain Capital-backed Surgery Partners operates through a network of ambulatory surgery centers, surgical hospitals and physician partnerships.
Surgery Partners rises 46.3%
Surgery Partners (SGRY) is up 46.3%, or $7.30 to $23.05.
Surgery Partners downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Ben Hendrix downgraded Surgery Partners (SGRY) to Sector Perform from Outperform with a price target of $23.50, up from $19, after the company agreed to be acquired…
Surgery Partners rises 46.2%
Surgery Partners (SGRY) is up 46.2%, or $7.27 to $23.02.
Surgery Partners trading resumes
09:55 EDT Surgery Partners (SGRY) trading resumes
Healthspan to acquire Surgery Partners in $5.7B all-cash transaction
09:07 EDT Healthspan to acquire Surgery Partners (SGRY) in $5.7B all-cash transaction
Healthspan to acquire Surgery Partners in $5.7B all-cash transaction
HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health, and Surgery Partners (SGRY) announced a definitive agreement under which HealthSpan Par...
HealthSpan Partners to Acquire Surgery Partners, Establishing a Leading Outpatient Surgical Care Platform
CINCINNATI & BRENTWOOD, Tenn.--(BUSINESS WIRE)--HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), and Surgery Partners, Inc. (NA...
Surgery Partners trading halted, news pending
08:16 EDT Surgery Partners (SGRY) trading halted, news pending
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on October 26, 2026, providing details for shareholder voting and corporate governance matters.
Bon Secours nears takeover of Surgery Partners, valued at $20 a share, FT says
Bon Secours Mercy Health is in late-stage discussions to purchase a majority stake in Surgery Partners (SGRY), which would value the group at $20 a share, Oliver Barnes of The…
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announ...
Surgery Partners price target raised to $15 from $14 at JPMorgan
JPMorgan analyst Benjamin Rossi raised the firm’s price target on Surgery Partners (SGRY) to $15 from $14 and keeps a Neutral rating on the shares. The firm updated the company’s…
Surgery Partners price target raised to $19 from $17 at TD Cowen
TD Cowen raised the firm’s price target on Surgery Partners (SGRY) to $19 from $17 and keeps a Buy rating on the shares. The firm said Management reiterated 2026 revenue/EBITDA…
Surgery Partners’ improved cash conversion not priced in, says Cantor Fitzgerald
Surgery Partners (SGRY)’ Idaho Falls divestiture should improve cash conversion, reduce leverage, and accelerate ex-Idaho Falls organic growth, reinforcing the long-term growth outlook alongside favor...
Surgery Partners Earnings Call Transcript: Q2 2026
Second quarter results exceeded expectations, with revenue and adjusted EBITDA growth driven by higher acuity procedures and strong physician recruitment. The pending Idaho Falls divestiture will simplify the business, reduce leverage, and sharpen focus on core short-stay surgical facilities. Full-year guidance is reaffirmed, with updated outlook to follow transaction close.
Surgery Partners Earnings release: Q2 2026
Surgery Partners released its Q2 2026 earnings on August 10, 2026, summarizing the period's financial results.
Surgery Partners Slides: Q2 2026
Surgery Partners has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 10, 2026.
Surgery Partners Quarterly report: Q2 2026
Surgery Partners has published its Q2 2026 quarterly earnings report on August 10, 2026.